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Introduction
Juvenile nasopharyngeal angiofibroma (JNA) is a hypervascular, slow growing, and locally destructive tumor. The tumor is histologically 
benign, however, JNA is aggressive and destructive, spreading from sphenopalatine foramen with extension occurring into the osseous and soft tissue structures.1,2 The 
incidence of JNA is 0.05–0.5% of all head-neck tumors, and is relatively higher in India 
and Egypt compared to America and Europe. 
In Asia and the Middle East, the incidence 
is around 1:5,000 and 1:60,000. The lesion mostly affects adolescent males with the 
highest incidence between 14–18 years old.3
The JNA presents clinically with nasal 
obstruction, recurrent epistaxis, facial 
numbness, ear fullness, rhinorrhea, cheek swelling, sinusitis, nasopharyngeal mass, headaches, visual changes, proptosis, and 
orbital involvement.1,2,4 The diagnosis of 
JNA is based on history taking and physical 
examination, confirmed by multiplanar imaging 
studies such as Computed Tomography (CT) 
or Magnetic Resonance Imaging (MRI).5,6 The 
CT scan helps in better delineation of osseous involvement of tumor, while MRI is useful for assessing intracranial extension. Moreover, 
the CT angiography is used to define the tumor 
blood supply and the vascular composition of 
the tumor since the JNA is highly vascular and 
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Abstract
Background: Juvenile nasopharyngeal angiofibroma (JNA) is a fibrovascular tumor originating from 
the supero-posterior area of the sphenopalatine foramen. This tumor is histologically benign, but is 
clinically malignant because JNA has potentially destructive spread extending to the skull base and the 
cranium. The aim of the study was to evaluate the management of JNA in Dr. Hasan Sadikin General Hospital Bandung, a referral hospital in West Java.
Methods: This was a descriptive retrospective study using medical record data of JNA patients during 
the period of 2011-2018. The stage of JNA was designated, based on the FISCH classification.
Results: There were112 JNA cases, consisting of 99% male and 1% female. Most of them (97%) were 
aged 10-20 years old (median16 years old). The chief complaints were nasal obstruction (46%) and 
recurrent epistaxis (36%). Most of the JNA stage was stage II (43%). Major feeding vessel of JNA 
was from an internal maxillary artery (IMAX) and ascending pharyngeal artery (28%). Preoperative 
management was equal for ligation and embolization. The complication of embolization was local pain 
(75%). The most surgical technique performed was the transpalatal approach (41.36%). Blood loss 
in a different stage in JNA surgery with embolization was less than surgery with ligation. There were 
patients (10%)with residual disease after 6 months follow-up.
Conclusions: JNA is essentially a disease of the adolescent males. The management of JNA patients 
is surgery, mostly using transpalatal technique. Preoperative embolization of JNA is a safe procedure, 
minimizes intraoperative blood loss, decrease the incidence of residual or recurrence, and shortening the duration of the surgery.
Keywords: Embolization, FISCH classification, internal maxillary artery, juvenile nasopharyngeal   
        angiofibroma, ligation
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predominantly blood supplied via the branches 
of External Carotid Artery (ECA), mainly from 
the internal maxillary artery (IMAX), multiple 
branches of ipsilateral ECA, contralateral ECA, 
and InternalCarotidArtery (ICA).2Surgery is the mainstay of treatment 
for JNA.1,4,6 The surgical approaches are including transpalatal, lateral rhinotomy, 
facial degloving, or endoscopy technique.1,7 
Since JNA is an aggressive tumor with a strong 
tendency to bleed, the surgical resection 
can be complicated by massive hemorrhage. 
An important advancement in treatment is 
preoperative intra-arterial embolization, which is now widely accepted and performed to 
reduce blood flow to the tumor. An alternative way is carotid artery ligation, as some hospitals may lack the facilities and infrastructure 
required for embolization.2 In addition to the 
management of JNA, the recurrence rate is also an important factor. Patients younger than 18 
years have a recurrence rate of 48.2%. The study exploring the characteristics of preoperative 
management of JNA, intraoperative blood loss, postoperative complications, and recurrence of 
JNA in Indonesia is still very limited. Therefore, our study aimed to evaluate the management 
of JNA in Dr. Hasan Sadikin General Hospital 
Bandung, as a referral hospital in West Java Indonesia.
Methods
A descriptive retrospective hospital-based study was conducted in Dr. Hasan Sadikin General Hospital, a referral hospital in West 
Java, reviewing the management of JNA 
by collecting a medical records of patients 
with JNA from 2011 to 2018. The inclusion criteria were complete medical record data on patients underwent preoperative ligation 
before surgical resection (group A) and patients underwent preoperative intraarterial 
embolization before surgical resection (group 
B). All patients were operated by the same 
team of surgeon and evaluation of the blood 
loss was also conducted by the same team of nursing staff.
The classification of FISCH was used for staging. Stage I was designated as tumor limited to the nasopharynx and nasal cavity with no 
bone destruction, Stage II was designated as a tumor invading the pterygomaxillary fossa, the maxillary antrum, the ethmoid and sphenoid 
sinuses with bone destruction. Furthermore, stage III was designated as tumor invading 
Table 1 The Distribution Chief Complains among Juvenile Nasopharyngeal Angiofibroma 
  Patients (n=112) from Dr. Hasan Sadikin General Hospital year 2011–2018
Chief Complain n %
Nasal obstruction 52 46Recurrent epistaxis 40 36Headache 11 10Protruding Nasal Mass 8 7Proptosis 1 1Facial swelling - -
Table 2 The Distribution of Major Feeding Vessel among Juvenile Nasopharyngeal 
   Angiofibroma Patients based on CT Angiography
Major Feeding Vessel Number of patients %
IMAX 23 21
Ascending pharyngeal artery 8 7
IMAX & ascending pharyngeal artery 31 28Bilateral supply 13 12Unilateral supply 29 26
Internal Carotid Artery 8 7Note: IMAX= internal maxillary artery
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the infratemporal fossa, the orbit, and the 
parasellar area, but remaining lateral to the cavernous sinus, and stage IV was designated as tumor with invasion of the cavernous sinus, the optic chiasm or the pituitary fossa.
Preoperative embolization and angiography 
were performed by experienced interventional radiologist. Surgery was performed within 
24–72 hours after embolization. Surgical approach depended upon the stage of the tumor and approaches used were endoscopic approach, lateral rhinotomy, transpalatal and 
facial degloving. Blood loss was estimated by 
measuring the total fluid collected by suction 
and blood absorbed by gauze pieces. All data 
were described in percentage and presented 
in tables or figures.
Results
In total, there were 112 medical record data 
from 2011 to 2018, consisting of a male 
(n=111; 99%) and only one female. The age 
was predominantly (n=109;97%) between 
10–20 years old (median 16 years old). The primary presenting symptoms were nasal 
obstruction (n=52;46%) and recurrent 
epistaxis (n=40; 36%) (Table 1).The tumors were staged according to the 
FISCH Staging, consisting of stage I (n=29;26%), 
stage II (n=48;43%), stage III (n=27;24%) 
and stage IV (n=8;7%), respectively. The CT 
angiography examination showed that 28% 
had blood supply from the internal maxillary 
artery (IMAX) and ascending pharyngeal 
artery, 26% from the unilateral supply, and 
12% from the bilateral supply. The IMAX was 
also shared in the arterial supply (21%), and 
ascending pharyngeal artery (7%) (Table 2).Preoperative methods performed in 
112 JNA patients were by ligation of the 
external carotid artery (n=54;48%) and by 
embolization (n=58;52%) (Figure 1), whereas 
surgical approaches for JNA were based on the stage of the tumor, which are transpalatal 
technique (n=41), facial degloving (n=40), 
lateral rhinotomy (n=9), and closed approach 
or endoscopic resection) (n=22).
Figure1  Preoperative Methods in Juvenile Nasopharyngeal Angiofibroma Patients
Table 3 Blood Loss in a Different Stage of Juvenile Nasopharyngeal Angiofibroma Patients 
  Based on Ligation and Embolizationa
Stage
Group A Group B
No. subjects % Blood Loss (mL)* No. subjects %
Blood Loss 
(mL)*Stage I 14 26 330 15 26 240Stage II 23 43 660 25 43 450Stage III 13 24 820 14 24 600Stage IV 4 7 1200 4 7 900
Note: Blood loss in the group underwent ligation (group A) and embolization (group B). * mean blood loss
n n
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Intraoperative blood loss was measured 
by calculating the volume of blood that 
was collected in tubes. Description of 
intraoperative blood loss, vascular supply, and stage for a tumor that underwent 
ligation (group A) was presented side by 
side with those with embolization (group B). 
Preoperative embolization has been effective 
in decreasing intraoperative blood loss than 
artery ligation. Intraoperative blood loss from 
surgery with ligation ranges from 330–1200 
ml and preoperative embolization ranges from 
240–900 ml (Table 3).Of the total 58 patients who performed 
preoperative embolization, several complications were found, predominantly as 
local pain (n=43;26%) (Table 4). Postoperative complications and tumor recurrence 
remain the most tangible clinical outcomes. 
Postoperative imaging was conducted after 6 
months of follow-up, however, some patients 
were lost in follow up. Of 47 patients from 
Group A (ligation group), 4 had a residual 
disease and 45 patients from Group B 
(embolization group), 7 had residual disease. No patients were dead in this case.
Discussions
This study reported that JNA patients registered in Dr. Hasan Sadikin General 
Hospital are predominantly (99%) males, and 
a majority in the age group of 10–20 years 
with a median age of 16 years old. Our study 
is similar to a study that reported that the JNA has a predilection in the adolescent males with 
an age range of 7–21 years, and the highest 
incidence is between the age of 14–18 years.4 The etiology of this tumor is not known yet, however, there are several theories, one of 
those is due to hormonal imbalance such as excessive estrogen production or androgen 
deficiency. Based on this theory, there is a 
relationship between the tumor with gender and age of the patients.4,8
Patients with JNA present with a variety 
Table 4 Complications of Preoperative Embolization of among Juvenile Nasopharyngeal 
  Angiofibroma Patients
Complication Number of Patients %Local pain 43 74Nausea 8 14
Local Subcutaneous edema 5 9Temporary visual loss 1 2Stroke 1 2
Figure 2 Postoperative Imaging as Follow-up after 6 Months of Surgery
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of major complaints. In this study, the most common complaints are nasal congestion 
and epistaxis similar to the symptoms of JNA 
reported such as nasal congestion (80–90%), 
recurrent epistaxis (45–60%), headache 
(25%) that occurs when the tumor has spread to the paranasal sinuses, and facial swelling 
(10–18%). Other symptoms such as anosmia, deafness, rhinolalia, cheek deformity, and 
palate swelling can also be found in patients 
with JNA. Nasopharyngeal angiofibroma is 
difficult to palpate, and a touch of a finger on the surface of the tumor can cause massive 
bleeding.8,9
Juvenile nasopharyngeal angiofibroma is 
hypervascular and predominantly supplied by 
the external carotid artery (ECA) circulation 
via the IMAX. They are associated with 
morbidity from local mass effect, bony 
erosion and remodeling of the bone, nasal 
obstruction, haemorrhage, and cranial nerve palsies. These tumors are surgically resected with the open procedure in ligation 
of ECA to decrease intraoperative blood loss. 
Preoperative embolization is performed to 
these tumors by interventional radiology and 
then resected by open surgery or by using 
endoscopy. The purpose of embolization is 
to decrease intraoperative blood loss. The 
blood supply for JNAs can be variable, with 
blood supply from multiple branches of the 
ECA, contralateral ECA branches, and small 
branches arising from the internal carotid 
artery (ICA). The CT angiography performed 
during the preoperative embolization 
procedure delineates the specific blood supply 
to JNA, allowing the surgeon to plan a surgical approach, anticipate areas of increased 
bleeding.2,10,11
The extirpation surgery technique that is often used is the transpalatal approach. The 
choice of surgical approach in JNA is generally 
based on the location, size, and extension of the tumor to the surrounding tissue, age and general condition of the patient, successful 
embolization before surgery and the experience of the surgeon.10In this study, all cases managed with surgery 
as the main therapy for JNA such as transpalatal surgery, facial degloving, endoscopic surgery, and surgery using a lateral rhinotomy. Before the surgical removal of the tumor, external 
carotid artery ligation has been performed to some respondents, and others with 
embolization. Preoperative embolization of 
the JNA makes it easier to identify anatomical landmarks during surgery without massive 
bleeding and facilitating the procedure. 
Consequently, preoperative embolization 
helps to reduce surgical morbidity.11–13Endoscopic surgery has many advantages compared to traditional approaches, as this has a wider view of the tumor and anatomical 
landmarks from several angles become 
possible, better visualization of the interface 
between the tumor and adjacent bone and soft tissues. The result is more accurate and 
complete resection for control of bleeding 
can be performed. Another advantage of endoscopic surgery is that incisions for skin, mucosa, and osteotomies are unnecessary, affecting less the growth of the midface of adolescents. Incisions and closure were not needed, reduces the duration of the operation and postoperative complications, such as pain, dysesthesia, and trismus.2,14
All patients have been followed up with endoscopic examination and CT scan after 
six months postoperatively. Although most of them have no residual disease, some have residual disease. Predicting the recurrence of 
JNA is influenced by the age and the tumor stage of the patients. The higher chances of recurrence are younger and the later stage of 
JNA. Early diagnosis not only helps in better 
management but also prevents recurrences.15The limitation of this study is that the data collected is from the medical records and 
follow up cannot be controlled, therefore, the 
follow-up data is not properly evaluated.
As a conclusions, JNA is a common disease of adolescent males, with the major feeding vessels are from the internal maxillary artery and ascending pharyngeal artery. The common 
chief complaints arenasal obstruction and epistaxis. The stage II has predominantly 
occurred. The management of JNA in West Java is surgery, mostly using a transpalatal 
technique. Preoperative embolization of JNA 
is a safe procedure without any substantial risk of neurological complications, that can 
minimize intraoperative blood loss, leading to a decreased incidence of residual or recurrence, and shortened operation duration. 
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